StockData
Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc. (CODX) stock

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.28−0.01 (-3.78%)

Close on Nov 11, 2026Market cap $1.74MP/E –Yield –

Co-Diagnostics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Co-Diagnostics's enterprise value was -$2.29M on Nov 11, 2026, against $6.40M a year earlier. Over the last 5 years it ranged from -$41.89M to $174.12M, with a median of -$7.07M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$2.29M–
2025Dec 31, 2025-$3.33M–
2024Dec 31, 2024-$13.71M–
2023Dec 29, 2023-$22.65M–
2022Dec 30, 2022-$8.58M-104.9%
2021Dec 31, 2021$174.12M-25.8%
2020Dec 31, 2020$234.62M+1696.6%
2019Dec 31, 2019$13.06M-21.8%
2018Dec 31, 2018$16.69M-40.0%
2017Dec 29, 2017$27.84M–

More Co-Diagnostics figures

See a number that looks wrong?